We have collected information about Obesity Drug Delivery for you. Follow the links to find out details on Obesity Drug Delivery.
https://www.sciencedirect.com/science/article/pii/S1043276019302012
A variety of novel drug delivery strategies for obesity treatment have been developed to provide a targeted or intelligent platform to release therapeutics in a spatiotemporally controlled manner, thereby achieving enhanced antiobesity efficacy and reduced toxicity.Author: Di Huang, Meng Deng, Shihuan Kuang
https://www.onlinelibrary.wiley.com/doi/10.1002/adhm.201801184
This review provides an introduction to obesity and obesity‐related comorbidities. The most recent developments of nanotechnology‐based drug delivery strategies are highlighted and discussed. Additionally, challenges and consideration for the development of nanoformulations with translational potential are discussed.Author: Yung‐Hao Tsou, Bin Wang, William Ho, Bin Hu, Pei Tang, Sydney Sweet, Xue‐Qing Zhang, Xiaoyang Xu
https://www.azonano.com/article.aspx?ArticleID=4635
Sep 21, 2017 · The highly specific drug delivery of the microneedle patches in this study show a promising future for the treatment of obesity, especially for individuals who are unable to afford large-scale weight reduction procedures.
https://www.novonordisk.com/products.html
Who we are. Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders.We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease.
https://www.ncbi.nlm.nih.gov/pubmed/29623548
However, most of the anti-obesity drugs often show poor outcome for weight-loss and cause severe adverse effects. This review surveys recent advances in nanomedicine as an emerging strategy for obesity treatment with an emphasis on the enhanced therapeutic efficiency and minimized side effects. The insights for future development are also ...Author: Yuqi Zhang, Jicheng Yu, Li Qiang, Zhen Gu
https://www.sciencedaily.com/releases/2016/05/160502161116.htm
May 02, 2016 · Delivery challenges. With the current system, the particles are injected intravenously, which could make this approach suitable for morbidly obese patients who are at significant risk of obesity ...
https://www.sciencedaily.com/releases/2019/10/191030100045.htm
Oct 30, 2019 · This method is known in science as drug delivery. Chemistry professor Ann-Christin Pöppler from Julius-Maximilians-Universität (JMU) Würzburg in …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467838/
Orlistat is a drug, used to treat Obesity by inhibiting pancreatic lipase enzyme. It is highly lipophilic having bioavailability of less than 1%. Self-microemulsifying drug delivery system (SMEDDS), being lipid based formulation can its increase the bioavailability.Author: Jagruti Desai, Nirav Khatri, Sachin Chauhan, Avinash Seth
https://www.drugs.com/condition/obesity.html
76 rows · About Obesity: More than half of the U.S. population is overweight. But being obese is …
https://www.pnas.org/content/113/20/5552
May 17, 2016 · Obesity has been recognized by the American Medical Association to be a disease affecting significant portions of the population and is related to an expansion and proliferation of white adipose tissue (WAT) in the body. The primary function of WAT is to store energy, whereas brown adipose tissue (BAT) generates heat through energy expenditure.Author: Yuan Xue, Xiaoyang Xu, Xiaoyang Xu, Xiaoyang Xu, Xue-Qing Zhang, Omid C. Farokhzad, Robert Langer
Searching for Obesity Drug Delivery?
You can just click the links above. The data is collected for you.
